Thanks for posting the specifics,
@foreverbull Like I said, I personally think that a lot of those objections aren't actually true and have been sufficiently refuted by those who helped craft the guidelines.
My takeaway from all of the information is that the main concerns are:
1. no longterm or non-RCT research was included in the findings
2. RCTs have limited generalizability, yet APA was willing to endorse RCT-based treatments for all individuals (the findings ignore cultural factors, rely on a one-size-fits-all approach, and ignore comorbidity issues)
4. this can be used to restrict practice to APA-endorsed treatments via insurance company endorsement/control
5. attrition rates were not adequately considered when endorsing the actual use of these treatments
6. psychologists could eventually be punished via state boards/complaints if practicing other treatments for PTSD with research support that do not have APA endorsement (when taken to the extreme)
Per APA's guideline: "In addition to these strengths, the guideline also has some limitations. Gaps in the
current empirical literature regarding treatment comparisons, evaluation of moderators of treatment effects, inclusion of participants with comorbidities, measurement of potential side effects and harms, and assessment of important outcomes and the timing of their assessment all need to be addressed to answer important clinical questions. Additionally, methodological improvements that minimize attrition/dropout, decrease missing data and ensure sufficient power will improve the quality of the findings and hence the possible conclusions that can be drawn. Finally, the panel did not have data on which to make recommendations for some treatments in use because they arise from traditions with non-RCT research practices or the quality of the research base has not been subjected to the level of critical appraisal of
systematic review."
These are serious limitations that should be considered, but I don't disagree that the endorsed treatments are effective for certain clients. I was trained in PE, and it is effective for those who can tolerate it. These treatments that are endorsed are fine in general as different tools for use with PTSD, but aren't for everyone. Not all folks can tolerate PE per the standard protocol. What would be the alternative in APA's terms? CPT, CBT, Brief Psychodynamic, EMDR, Relaxation and pharmacological treatments only?
Interpersonal therapy has research support, but didn't make the cut because we need more studies in this area (we have a few supporting its use, but we need more). Mindfulness may also decrease PTSD symptoms, but we don't have enough research yet. I'm sure there are other approaches as well. If APA endorses a few and ignores alternative treatment possibilities, will we get to continue to explore/research these and other treatments or will they fall by the wayside and be labeled "unscientific" or "unsupported" because no one wants to research them now to see if they are just as effective?
To me, the guidelines highlight the issue of fads in research, that is to say, a flurry of research will come out for a particular treatment, and other promising treatments may get ignored or not researched because they aren't popular.
Absolutely use the methods that have a solid body of support, AND lets research others and not fully endorse treatments until we have broad research on a wide range of treatments for PTSD rather than just a few. RCTs are our "gold standard," but I'd like to see additional types of research included as well as RCTs for other treatments.